PL1886169T5 - Urządzenia okulistyczne do przedłużonego uwalniania związków czynnych - Google Patents

Urządzenia okulistyczne do przedłużonego uwalniania związków czynnych

Info

Publication number
PL1886169T5
PL1886169T5 PL06742806T PL06742806T PL1886169T5 PL 1886169 T5 PL1886169 T5 PL 1886169T5 PL 06742806 T PL06742806 T PL 06742806T PL 06742806 T PL06742806 T PL 06742806T PL 1886169 T5 PL1886169 T5 PL 1886169T5
Authority
PL
Poland
Prior art keywords
active compounds
sustained delivery
ophthalmic devices
ophthalmic
sustained
Prior art date
Application number
PL06742806T
Other languages
English (en)
Other versions
PL1886169T3 (pl
Inventor
Lynn Cook Winterton
John Martin Lally
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37027620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1886169(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL1886169T3 publication Critical patent/PL1886169T3/pl
Publication of PL1886169T5 publication Critical patent/PL1886169T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00—Producing optical elements, e.g. lenses or prisms
    • B29D11/00009—Production of simple or compound lenses
    • B29D11/00038—Production of contact lenses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00—Producing optical elements, e.g. lenses or prisms
    • B29D11/00865—Applying coatings; tinting; colouring
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041—Lenses
    • G02B1/043—Contact lenses

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physics & Mathematics (AREA)
  • Mechanical Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Eyeglasses (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
PL06742806T 2005-05-05 2006-05-04 Urządzenia okulistyczne do przedłużonego uwalniania związków czynnych PL1886169T5 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US67796405P 2005-05-05 2005-05-05
US71987805P 2005-09-23 2005-09-23
EP06742806.0A EP1886169B2 (en) 2005-05-05 2006-05-04 Ophthalmic devices for sustained delivery of active compounds
PCT/EP2006/004193 WO2006117228A2 (en) 2005-05-05 2006-05-04 Ophthalmic devices for sustained delivery of active compounds

Publications (2)

Publication Number Publication Date
PL1886169T3 PL1886169T3 (pl) 2011-05-31
PL1886169T5 true PL1886169T5 (pl) 2016-05-31

Family

ID=37027620

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06742806T PL1886169T5 (pl) 2005-05-05 2006-05-04 Urządzenia okulistyczne do przedłużonego uwalniania związków czynnych

Country Status (19)

Country Link
US (2) US9804295B2 (pl)
EP (1) EP1886169B2 (pl)
JP (1) JP5053261B2 (pl)
CN (1) CN101171531B (pl)
AR (1) AR055931A1 (pl)
AT (1) ATE493679T2 (pl)
AU (1) AU2006243345B2 (pl)
BR (1) BRPI0611434A2 (pl)
CA (1) CA2606073C (pl)
DE (1) DE602006019234D1 (pl)
DK (1) DK1886169T4 (pl)
ES (1) ES2357623T5 (pl)
MX (1) MX2007013739A (pl)
NO (1) NO340948B1 (pl)
PL (1) PL1886169T5 (pl)
PT (1) PT1886169E (pl)
TW (1) TWI375571B (pl)
WO (1) WO2006117228A2 (pl)
ZA (1) ZA200708953B (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2824301C (en) 2005-11-25 2016-01-12 Novartis Ag F, g, h, i and k crystal forms of imatinib mesylate
WO2008073193A2 (en) * 2006-11-06 2008-06-19 Novartis Ag Ocular devices and methods of making and using thereof
US20080152540A1 (en) * 2006-12-22 2008-06-26 Bausch & Lomb Incorporated Packaging solutions
TWI419719B (zh) 2007-08-31 2013-12-21 Novartis Ag 隱形眼鏡產物
KR101535692B1 (ko) * 2007-08-31 2015-07-09 노파르티스 아게 콘택트 렌즈 포장 용액
EP2240804B1 (en) * 2008-01-14 2023-02-15 CooperVision International Limited Polymerizable contact lens formulations and contact lenses obtained therefrom
JP4869274B2 (ja) * 2008-03-21 2012-02-08 株式会社メニコン ソフトコンタクトレンズ包装製品及びソフトコンタクトレンズの包装方法
WO2010011492A1 (en) 2008-07-21 2010-01-28 Novartis Ag Silicone hydrogel contact lenses with convertible comfort agents
US20100106128A1 (en) * 2008-10-23 2010-04-29 Shane Mao Contact lens cases for delivery of ophthalmic agents
AU2012268828B2 (en) * 2008-12-05 2013-09-05 Alcon Inc. Ophthalmic devices for delivery of hydrophobic comfort agents
TWI506333B (zh) * 2008-12-05 2015-11-01 Novartis Ag 用以傳遞疏水性舒適劑之眼用裝置及其製造方法
US8414912B2 (en) * 2008-12-11 2013-04-09 Massachusetts Institute Of Technology Contact lens drug delivery device
KR101652553B1 (ko) * 2009-02-20 2016-08-30 가부시키가이샤 시드 약물 서방성 하이드로겔 콘택트렌즈 및 약물 서방성 하이드로겔 콘택트렌즈를 사용한 약물 방출 방법
EP2555751B8 (en) * 2010-04-03 2018-02-14 Praful Doshi Methods of coating a contact lens
EP2598317B2 (en) 2010-07-30 2019-11-06 CooperVision International Holding Company, LP Ophthalmic device molds and related methods
EP2718751B1 (en) 2011-06-09 2015-07-22 Novartis AG Silicone hydrogel lenses with nano-textured surfaces
US8784867B2 (en) 2011-12-21 2014-07-22 Novartis Ag Contact lenses containing carotenoid and method for making same
US9351827B2 (en) * 2012-04-03 2016-05-31 Johnson & Johnson Vision Care, Inc. Lens driver for variable-optic electronic ophthalmic lens
US9827250B2 (en) * 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
HUE044106T2 (hu) 2014-12-17 2019-09-30 Novartis Ag Újrahasználható lencseformázó szerszámok és eljárás azok használatára
EP3233449B1 (en) 2014-12-17 2019-07-24 Novartis AG Reusable lens molds and methods of use thereof
JP6595120B2 (ja) 2015-12-03 2019-10-23 ノバルティス アーゲー コンタクトレンズパッケージング溶液
SG11201803723QA (en) 2015-12-17 2018-07-30 Novartis Ag Reusable lens molds and methods of use thereof
US20180092776A1 (en) 2016-09-30 2018-04-05 Sara Heikali Method and device for treating and managing diseased ocular tissue
EP4234025A3 (en) 2017-08-11 2024-04-24 Unity Biotechnology, Inc. Treatment of diabetic retinopathy using pharmaceutical agents that eliminate senescent cells
JPWO2020166517A1 (ja) * 2019-02-12 2021-12-16 株式会社クラレ ポリマー組成物、ゲル、フィルムおよび粒子
KR20220034199A (ko) * 2019-09-18 2022-03-17 알콘 인코포레이티드 습식-패킹 소프트 하이드로겔 안구 삽입물
US20210132411A1 (en) 2019-11-04 2021-05-06 Alcon Inc. Contact lenses with surfaces having different softness
CN111116798B (zh) * 2019-12-24 2021-07-23 中国科学院广州能源研究所 一种改性的天然气水合物动力学抑制剂
EP4189469A1 (en) 2020-07-28 2023-06-07 Alcon Inc. Contact lenses with softer lens surfaces
US20240092043A1 (en) 2022-08-17 2024-03-21 Alcon Inc. Contact lens with a hydrogel coating thereon

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128305C (pl) 1963-09-11
DE2839249A1 (de) 1977-09-12 1979-03-22 Toray Industries Verfahren zur herstellung einer weichen kontaktlinse und ausgangsloesung zur durchfuehrung des verfahrens
JPS5590928A (en) * 1978-12-29 1980-07-10 Olympus Optical Co Ltd Endoscope objective lens which performs changing of magnification and focusing simultaneously
US4312575A (en) 1979-09-18 1982-01-26 Peyman Gholam A Soft corneal contact lens with tightly cross-linked polymer coating and method of making same
US4444711A (en) 1981-12-21 1984-04-24 Husky Injection Molding Systems Ltd. Method of operating a two-shot injection-molding machine
US4460534A (en) 1982-09-07 1984-07-17 International Business Machines Corporation Two-shot injection molding
US4625007A (en) 1982-09-30 1986-11-25 Polymer Technology Corporation Silicone-containing contact lens material and contact lenses made thereof
US5266563A (en) * 1984-06-11 1993-11-30 Biomatrix, Inc. Hyakyribate-poly (ethylene oxide) mixtures
US4713244A (en) 1985-08-16 1987-12-15 Bausch & Lomb Incorporated Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent
US4883658A (en) 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4744980A (en) 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4810764A (en) 1988-02-09 1989-03-07 Bausch & Lomb Incorporated Polymeric materials with high oxygen permeability and low protein substantivity
US4910277A (en) 1988-02-09 1990-03-20 Bambury Ronald E Hydrophilic oxygen permeable polymers
US5177165A (en) 1990-11-27 1993-01-05 Bausch & Lomb Incorporated Surface-active macromonomers
BR9206601A (pt) 1991-09-12 1995-10-17 Bausch & Lob Inc Método para fazer uma composição de hidrogel molhável contendo silicone, composição de hidrogel contendo silicone, dispositivo biomédico e lente de contato
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
AU5092493A (en) 1992-09-08 1994-03-29 Allergan, Inc. Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle
US6800225B1 (en) 1994-07-14 2004-10-05 Novartis Ag Process and device for the manufacture of mouldings and mouldings manufactured in accordance with that process
ATE159886T1 (de) * 1993-07-29 1997-11-15 Ciba Geigy Ag Verfahren und vorrichtung zur herstellung von formkörpern
TW272976B (pl) 1993-08-06 1996-03-21 Ciba Geigy Ag
EP0655470B1 (de) 1993-11-26 1999-05-12 Novartis AG Vernetzbare Copolymere und Hydrogele
US5712356A (en) 1993-11-26 1998-01-27 Ciba Vision Corporation Cross-linkable copolymers and hydrogels
US5894002A (en) 1993-12-13 1999-04-13 Ciba Vision Corporation Process and apparatus for the manufacture of a contact lens
US5843346A (en) 1994-06-30 1998-12-01 Polymer Technology Corporation Method of cast molding contact lenses
US6407145B1 (en) 1994-08-04 2002-06-18 Novartis Ag Photocrosslinkable materials and applications
US5665840A (en) 1994-11-18 1997-09-09 Novartis Corporation Polymeric networks from water-soluble prepolymers
EP0712867B1 (de) 1994-11-18 1999-07-14 Novartis AG Polymere Netzwerke aus wasserlöslichen Präpolymeren
TW349967B (en) 1995-02-03 1999-01-11 Novartis Ag Process for producing contact lenses and a cross-linkable polyvinylalcohol used therefor
EP0807269B1 (en) 1995-02-03 1999-10-20 Novartis AG Crosslinkable polymers containing photoinitiators
AU4438696A (en) 1995-02-03 1996-08-21 Novartis Ag Crosslinked polymers
ATE178414T1 (de) 1995-02-03 1999-04-15 Novartis Ag Vernetzte polymere enthaltend ester- oder amidgruppen
US5583463A (en) 1995-05-30 1996-12-10 Micron Technology, Inc. Redundant row fuse bank circuit
US5789462A (en) * 1995-09-13 1998-08-04 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Photocured crosslinked-hyaluronic acid contact lens
DE69705631T2 (de) 1996-10-21 2002-05-08 Novartis Ag Vernetzbare polymere
TW425403B (en) 1997-02-04 2001-03-11 Novartis Ag Branched polyurethane (meth)acrylate prepolymers, opthal-mic mouldings derived therefrom and processes for their manufacture
EP0867456A1 (de) 1997-02-04 1998-09-30 Novartis AG Ophthalmischer Formkörper
ES2175698T3 (es) 1997-02-21 2002-11-16 Novartis Ag Articulos de moldeo oftalmicos.
GB9711818D0 (en) 1997-06-06 1997-08-06 Bausch & Lomb Contact lens packing solutions and methods for improving the comfort of disposable contact lenses
WO1999011692A1 (en) 1997-09-03 1999-03-11 The Regents Of The University Of California Novel biomimetic hydrogel materials
US6479587B1 (en) 1997-09-16 2002-11-12 Novartis Ag Crosslinkable polyurea polymers
TW429327B (en) 1997-10-21 2001-04-11 Novartis Ag Single mould alignment
US6822016B2 (en) 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US6367929B1 (en) 1998-03-02 2002-04-09 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
US7052131B2 (en) 2001-09-10 2006-05-30 J&J Vision Care, Inc. Biomedical devices containing internal wetting agents
US6943203B2 (en) 1998-03-02 2005-09-13 Johnson & Johnson Vision Care, Inc. Soft contact lenses
US6039913A (en) 1998-08-27 2000-03-21 Novartis Ag Process for the manufacture of an ophthalmic molding
EP1002807A1 (en) 1998-11-20 2000-05-24 Novartis AG Functionalized resin derived from polyallylamine
MXPA02009352A (es) 2000-03-24 2003-02-12 Novartis Prepolimeros entrelazables o polimerizables.
US6811805B2 (en) 2001-05-30 2004-11-02 Novatis Ag Method for applying a coating
JP2003033454A (ja) 2001-07-23 2003-02-04 Endo Mfg Co Ltd ゴルフクラブヘッドの製造方法
AR038269A1 (es) * 2002-01-09 2005-01-12 Novartis Ag Articulos polimericos que tienen un recubrimiento lubrico, y metodo para fabricarlos
WO2004016671A1 (en) 2002-08-14 2004-02-26 Novartis Ag Radiation-curable prepolymers
US7235195B2 (en) * 2002-09-06 2007-06-26 Novartis Ag Method for making opthalmic devices
US20040116564A1 (en) 2002-11-27 2004-06-17 Devlin Brian Gerrard Stabilization of poly(oxyalkylene) containing polymeric materials
US20040115270A1 (en) 2002-12-13 2004-06-17 Dharmendra Jani Absorption and controlled release of polyethers from hydrogel biomaterials
US7387759B2 (en) 2002-12-17 2008-06-17 Novartis Ag System and method for curing polymeric moldings having a masking collar
US7384590B2 (en) 2002-12-17 2008-06-10 Novartis Ag System and method for curing polymeric moldings
US20040119176A1 (en) 2002-12-23 2004-06-24 Bausch & Lomb Incorporated Method for manufacturing lenses
EP1623269B2 (en) 2003-04-24 2022-08-31 CooperVision International Limited Hydrogel contact lenses and package systems and production methods for same
US7977430B2 (en) 2003-11-25 2011-07-12 Novartis Ag Crosslinkable polyurea prepolymers
US7786185B2 (en) 2004-03-05 2010-08-31 Johnson & Johnson Vision Care, Inc. Wettable hydrogels comprising acyclic polyamides
US7249848B2 (en) 2004-09-30 2007-07-31 Johnson & Johnson Vision Care, Inc. Wettable hydrogels comprising reactive, hydrophilic, polymeric internal wetting agents

Also Published As

Publication number Publication date
AU2006243345A1 (en) 2006-11-09
AU2006243345B2 (en) 2010-03-18
NO340948B1 (no) 2017-07-24
MX2007013739A (es) 2008-01-21
ATE493679T2 (de) 2011-01-15
PL1886169T3 (pl) 2011-05-31
DK1886169T3 (da) 2011-03-14
US9804295B2 (en) 2017-10-31
EP1886169A2 (en) 2008-02-13
CA2606073C (en) 2013-12-03
WO2006117228A3 (en) 2007-02-01
BRPI0611434A2 (pt) 2010-09-08
EP1886169B2 (en) 2015-12-09
TW200716201A (en) 2007-05-01
PT1886169E (pt) 2011-03-07
CN101171531B (zh) 2010-06-16
ES2357623T3 (es) 2011-04-28
ZA200708953B (en) 2008-06-25
US20170307780A1 (en) 2017-10-26
WO2006117228A2 (en) 2006-11-09
JP2008539837A (ja) 2008-11-20
US20060251696A1 (en) 2006-11-09
CA2606073A1 (en) 2006-11-09
NO20076252L (no) 2008-02-05
CN101171531A (zh) 2008-04-30
DK1886169T4 (en) 2016-03-14
TWI375571B (en) 2012-11-01
ES2357623T5 (es) 2016-03-29
EP1886169B1 (en) 2010-12-29
AR055931A1 (es) 2007-09-12
DE602006019234D1 (de) 2011-02-10
JP5053261B2 (ja) 2012-10-17

Similar Documents

Publication Publication Date Title
ZA200708953B (en) Ophthalmic devices for sustained delivery of active compounds
EP2012751A4 (en) NEW NANOPARTICLES FOR THE DELIVERY OF ACTIVE AGENTS
PL2058020T3 (pl) Urządzenie do podawania leków
HK1140139A1 (en) Multistage delivery of active agents
ZA200706622B (en) Microimplants for ocular administration
EP1903866A4 (en) IMPROVED RELEASE OF TETRAHYDROCANNABINOL
GB0524958D0 (en) Transdermal administration of active agents
PL2213168T3 (pl) Pestycydowe kombinacje substancji czynnych
IL208947A0 (en) Ophthalmic devices for the controlled release of active agents
EP2046736A4 (en) ARYLSULFANYL COMPOUNDS AND COMPOSITIONS FOR ACTIVE COMPOSITION
ZA200710734B (en) Compositions for drug delivery
GB0524961D0 (en) Transdermal administration of active agents for systemic effect
EP2018172A4 (en) ADMINISTRATION OF ACTIVE SUBSTANCES USING A CHOCOLATE CARRIER SUBSTANCE
IL185889A0 (en) Dispenser for delivering medicament
EP1776112A4 (en) HETEROCYCLIC COMPOUNDS AS PHARMACEUTICAL AGENTS
PL2154968T3 (pl) Kombinacje grzybobójczych substancji czynnych
EP1852106A4 (en) SOLID OPHTHALMIC MEDICINE FOR EXTERNAL USE
SG138567A1 (en) Punctal plugs for the delivery of active agents
SG138565A1 (en) Punctal plugs for the delivery of active agents
ZA200804952B (en) Fungicidal active substance combination
GB0402492D0 (en) Pharmaceutically active compounds
EP1858522A4 (en) PHARMACEUTICALLY ACCEPTABLE CARRIER FOR OPHTHALMIC COMPOSITIONS
EP1617847A4 (en) PROCEDURE FOR THE CONTROLLED DISPOSAL OF PHARMACOLOGICAL ACTIVE SUBSTANCES
SG138564A1 (en) Punctal plugs for the delivery of active agents
GB0517838D0 (en) Transdermal active principle delivery means